We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$91.3B
AUM Growth
+$6.27B
Cap. Flow
+$3.06B
Cap. Flow %
3.35%
Top 10 Hldgs %
13.7%
Holding
3,123
New
88
Increased
2,252
Reduced
349
Closed
49

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$99.8M
2
MSFT icon
Microsoft
MSFT
+$82.2M
3
PFE icon
Pfizer
PFE
+$61.6M
4
CL icon
Colgate-Palmolive
CL
+$60M
5
AMZN icon
Amazon
AMZN
+$59.9M

Sector Composition

Rank Sector Weight
1 Financials 14.91%
2 Technology 14.06%
3 Healthcare 12.49%
4 Industrials 11.09%
5 Consumer Discretionary 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPST icon
3051
Tempest Therapeutics
TPST
$14M
$87K ﹤0.01%
19
-2
-10% -$24.9K
MRTX
3052
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$86K ﹤0.01%
18,048
FLNT
3053
Fluent
FLNT
$104M
$84K ﹤0.01%
4,017
ADVM
3054
DELISTED
Adverum Biotechnologies
ADVM
$82K ﹤0.01%
2,821
AGRX
3055
DELISTED
Agile Therapeutics
AGRX
$77K ﹤0.01%
7
CRDF icon
3056
Cardiff Oncology
CRDF
$72.7M
$75K ﹤0.01%
491
APVO icon
3057
Aptevo Therapeutics
APVO
$4.92M
0
PN
3058
DELISTED
Patriot National, Inc.
PN
$74K ﹤0.01%
15,800
SNDX icon
3059
Syndax Pharmaceuticals
SNDX
$1.7B
$73K ﹤0.01%
10,100
NDLS icon
3060
Noodles & Co
NDLS
$111M
$72K ﹤0.01%
2,175
+19
+0.9% +$681
AVGR
3061
DELISTED
Avinger, Inc. Common Stock
AVGR
0
PRGX
3062
DELISTED
PRGX Global, Inc.
PRGX
$65K ﹤0.01%
11,000
AMPE
3063
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$64K ﹤0.01%
235
HBIO icon
3064
Harvard Bioscience
HBIO
$28.5M
$59K ﹤0.01%
1,930
CVRS
3065
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$59K ﹤0.01%
84,000
DMTX
3066
DELISTED
Dimension Therapeutics, Inc
DMTX
$57K ﹤0.01%
13,100
CYTR
3067
DELISTED
CytRx Corp
CYTR
$47K ﹤0.01%
21,000
ALR
3068
DELISTED
AlerisLife Inc
ALR
$39K ﹤0.01%
1,434
ANTH
3069
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$34K ﹤0.01%
6,492
VXRT
3070
DELISTED
Vaxart
VXRT
$32K ﹤0.01%
2,365
ARQL
3071
DELISTED
Arqule Inc
ARQL
$27K ﹤0.01%
21,000
SLS icon
3072
SELLAS Life Sciences
SLS
$2.21B
$26K ﹤0.01%
+9
New +$52.3K
IIP
3073
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$16K ﹤0.01%
10,152
-12,276
-55% -$19.3K
ELDN icon
3074
Eledon Pharmaceuticals
ELDN
$265M
$15K ﹤0.01%
93
MDY icon
3075
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
-1,400
Closed -$396K

Similar funds

Charles Schwab's Q4 2016 Portfolio in Review

As of Q4 2016, Charles Schwab held 3,123 positions worth $91.3B, up 7.4% from $85.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $3.06B of net new capital in Q4 2016, opening 88 new positions and adding to 2,252 existing holdings. Its largest new stake was Howmet Aerospace: 1,721,382 shares worth $24.5M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Huntington Ingalls Industries, an estimated $51.6M trimmed.

  • Charles Schwab's largest Q4 2016 buy was Howmet Aerospace: 1,721,382 shares worth $24.5M.
  • Charles Schwab added most to Apple in Q4 2016, an estimated $99.8M increase.
  • Charles Schwab's biggest Q4 2016 reduction was Huntington Ingalls Industries, cutting an estimated $51.6M.
  • Charles Schwab fully exited DONNELLEY R R & SONS CO in Q4 2016, selling an estimated $64.4M.
  • Charles Schwab's ten largest holdings make up 14% of its $91.3B portfolio in Q4 2016.
  • Charles Schwab opened 88 new positions and closed 49 in Q4 2016.
  • Charles Schwab's portfolio value rose 7.4% quarter-over-quarter to $91.3B.

Based on Charles Schwab's 13F filing for Q4 2016, filed 13 Feb 2017.